These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6548427)

  • 1. Intestinal absorption of calcium in greyhounds: the response to intermittent and continuous administration of human synthetic parathyroid hormone fragment 1-34 (hPTH 1-34).
    Podbesek RD; Mawer EB; Zanelli GD; Parsons JA; Reeve J
    Clin Sci (Lond); 1984 Dec; 67(6):591-9. PubMed ID: 6548427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds.
    Podbesek R; Edouard C; Meunier PJ; Parsons JA; Reeve J; Stevenson RW; Zanelli JM
    Endocrinology; 1983 Mar; 112(3):1000-6. PubMed ID: 6822201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of parathyroid hormone and the synthetic 1-34 amino-terminal fragment in rats and dogs.
    Stevenson RW; Parsons JA
    J Endocrinol; 1983 Apr; 97(1):21-30. PubMed ID: 6842124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the anabolic effect of synthetic human parathyroid hormone fragment-(I-34) in the bone of growing rats by variations in the dosage regimen.
    Riond JL
    Clin Sci (Lond); 1993 Aug; 85(2):223-8. PubMed ID: 8403791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients.
    Hodsman AB; Fraher LJ
    Bone Miner; 1990 May; 9(2):137-52. PubMed ID: 2161692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents.
    Yates AJ; Gutierrez GE; Smolens P; Travis PS; Katz MS; Aufdemorte TB; Boyce BF; Hymer TK; Poser JW; Mundy GR
    J Clin Invest; 1988 Mar; 81(3):932-8. PubMed ID: 3343349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.
    Slovik DM; Neer RM; Potts JT
    J Clin Invest; 1981 Nov; 68(5):1261-71. PubMed ID: 7298851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats.
    Schmitt CP; Hessing S; Oh J; Weber L; Ochlich P; Mehls O
    Kidney Int; 2000 Apr; 57(4):1484-92. PubMed ID: 10760084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in plasma calcium and in radiocalcium kinetics after termination of 5-week infusions of synthetic parathyroid peptide in dogs.
    Stevenson RW; Parsons JA; Podbesek RD; Reeve J
    Acta Endocrinol (Copenh); 1983 Dec; 104(4):462-7. PubMed ID: 6659845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human parathyroid hormone (PTH)-related protein and human PTH: comparative biological activities on human bone cells and bone resorption.
    Fukayama S; Bosma TJ; Goad DL; Voelkel EF; Tashjian AH
    Endocrinology; 1988 Dec; 123(6):2841-8. PubMed ID: 2848688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone.
    Liu CC; Kalu DN; Salerno E; Echon R; Hollis BW; Ray M
    J Bone Miner Res; 1991 Oct; 6(10):1071-80. PubMed ID: 1796755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium, and calcitriol metabolism and bone remodeling in postmenopausal women.
    Lieberman SA; Holloway L; Marcus R; Hoffman AR
    J Bone Miner Res; 1994 Nov; 9(11):1723-8. PubMed ID: 7863823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1-34) on rat bone.
    Uzawa T; Hori M; Ejiri S; Ozawa H
    Bone; 1995 Apr; 16(4):477-84. PubMed ID: 7605709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans.
    Everhart-Caye M; Inzucchi SE; Guinness-Henry J; Mitnick MA; Stewart AF
    J Clin Endocrinol Metab; 1996 Jan; 81(1):199-208. PubMed ID: 8550752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone-(1-34) administration in normal subjects.
    Slovik DM; Daly MA; Potts JT; Neer RM
    Clin Endocrinol (Oxf); 1984 Apr; 20(4):369-75. PubMed ID: 6325049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aluminum hydroxide on the parathyroid-vitamin D axis of postmenopausal women.
    Villa ML; Packer E; Cheema M; Holloway L; Marcus R
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1256-61. PubMed ID: 1955506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-Dihydroxyvitamin D production after stimulation with synthetic human parathyroid hormone (1-34) in hypoparathyroid and renal tubular disorders.
    Yasuda T; Nakajima H
    Endocrinol Jpn; 1984 Aug; 31(4):407-15. PubMed ID: 6097438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.